Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT — Stella

Recruiting

Back to Cytomegalovirus Infection Reactivation trials

Trial locations(1 site)

China

Anhui Provincial Hospital, Hefei, Anhui

Key details

Sponsor

Anhui Provincial Hospital

Enrollment target

~60 participants

Started

May 2024

Primary completion

May 2026

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov